Wednesday, August 14, 2019 11:59:17 AM
INCOMPLETE analysis! and only BSB online in last hour comments??
The critical analysis will demonstrate:
Over 3 years IF anyone could afford NVCR’s Optune
BEFORE any Insurance Reimbursements ie Medicare etc Is $720,000. Don't know if NVCR has ever commented on average patients length of use!
One time DCVAX L lasts 3 yrs for ~$150,000 plus?
So for the money NO CONTEST
For ALL the years NVCR Optune has been approved
for nGBM not a large ongoing customer base ( likely due to No Medicare CMS Reimbursement until this past June 2019!
Apparently everyone here just Pisses over NVCR:
AND it is clearly apparent NO ONE has parsed even
ONE of their CORPORATE PRESENTATIONS let alone a conference call. CLOSED mindsets! Yet another addition to the long procession of INCOMPLETE
Due Diligence on top of absence of preservation of capital via minimizing the runaway losses here!
STARK CONTRAST
On top of:
O/S Optune only 3-4 mos above SOC
O/S DCVAX L ~25 mos above SOC
ReOccurence stats for each?
Not to mention the daily 18 hr inconvenience
of head gear/ backpack
So clearly DISRUPTIVE DC technology platform
most especially with the promise of DIRECT’s impact!
That’s why
DIFFERENCE STROKES FOR DIFFERENT FOLKS
DIFFERENT STROKES FOR DIFFERENT FOLKS
Recent NWBO News
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/01/2024 10:04:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/02/2023 01:31:35 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 10:11:54 PM
- Epazz, Inc. (OTC Pink: EPAZ) ZenaDrone Demonstration to Defense Departments of UAE and Saudi Arabia • InvestorsHub NewsWire • 11/15/2023 12:19:31 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:30:39 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 • InvestorsHub NewsWire • 11/09/2023 01:00:34 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 Extreme Weather Demo • InvestorsHub NewsWire • 11/07/2023 12:29:43 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2023 08:36:14 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM